The newly-announced 130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.
Jun 22, 2021
Become a paying subscriber of Vancouver Tech Journal to get access to this post and other subscriber-only content.
Upgrade